Tag Archives: FDA

New Study Confirms: Millions of kids misdiagnosed with ADHD and drugged

by CCHR Int—A new study published today in the American Journal of Family Therapy has found that millions of children have been misdiagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and wrongly prescribed amphetamine-like drugs categorized by the U.S. Drug Enforcement Administration (DEA) in the same class of highly addictive drugs as cocaine, opium and morphine.

The study conducted by researchers at the New England Center for Pediatric Psychology and the Rhode Island College Department of Special Education found that of the “over 5 million children who are now being treated with ADHD medication, a majority may be suffering from Faux-ADHD, a disorder linked to irregular bedtimes” and that a majority of the children diagnosed ADHD may be unnecessarily medicated. Now while we at CCHR applaud any study on the issue of “ADHD” which is not ghost written by Big Pharma or those with a vested interest in drugging kids, we would like to pose two simple questions regarding this latest study…

Antidepressant tied to heart risk

High doses of the popular antidepressant Celexa (known as Cipramil in South Africa) can cause potentially fatal abnormal heart rhythms and should no longer be prescribed to patients, the US Food and Drug Administration has said.

Why Drug Companies Are Shy About Sharing On Facebook

People love how Facebook lets them comment on and share other people’s posts. But the idea of sharing on social media has got drug companies scared. When Facebook told drugmakers that they had to start allowing comments on their Facebook pages, some of those pages started disappearing.

“Take On Depression” suddenly disappeared. “ADHD Moms” vanished, too. So did “Epilepsy Advocate.” In the past, drug companies had been reluctant to create Facebook pages without a guarantee that they’d be closed to public comments — a unique accommodation on Facebook’s part. But that accommodation ended last week.

Two High Ranking Senators – Grassley & Kohl – Question Use of Psych Drugs in Nursing Homes

WASHINGTON — Two high-ranking senators have urged the Centers for Medicare and Medicaid Services (CMS) to take a closer look at potential over-prescribing of atypical antipsychotics to nursing home residents. Atypical antipsychotics are not approved to treat dementia, and must carry black box warnings that elderly people who take atypical antipsychotics have an increased risk of death, compared with those who take placebo pills for dementia. Still, it’s clear that these drugs are being used in nursing homes to control behavioral problems related to dementia. A 2011 report from the Department of Health and Human Services Office of the Inspector General (OIG) found that 14% of all nursing home residents with Medicare had claims for antipsychotics and 88% of the atypical antipsychotics prescribed off-label were for dementia.

And in 2009 Elli Lilly, the makers of olanzapine (Zyprexa), pled guilty and paid $1.4 billion to the federal government for allegedly targeting doctors who worked in nursing homes and assisted living facilities to prescribe olanzapine off-label to elderly patients with dementia. In their letter, Sens. Charles Grassley (R-Iowa) and Herb Kohl (D-Wisc.), urged CMS administrator Donald Berwick, MD, to examine the issue of overuse of antipsychotics in nursing homes more closely. The letter is a follow-up to one the senators sent in May after the release of the OIG report, which the senators themselves requested.

Twisted web of lies in Maryanne Godboldo Case: Big Pharma, multiple agencies, judge, DHS all profit from child abduction

There is a good chance you have heard the story of Maryanne Godboldo and how armed government agents broke down her door and attempted to kidnap her 13-year-old daughter Ariana to turn over to CPS because she refused to medicate her with a potentially dangerous and mind-altering anti-psychotic drug Risperdal (http://www.naturalnews.com/032191_C…). Maryanne had been using holistic remedies for her daughter instead, such as dance therapy.

The Detroit mother is now currently going through a criminal and custody trial because of this incident, and a variety of revealing and disturbing information is starting to come out about the involvement of Big Pharma and other parties in the twisted web of lies the case is wrapped in.

The jury presiding over the hearing was convinced to believe that Maryanne’s refusal to give her daughter the controversial drug, supposedly used to “treat” ADHD, represented a form of parental neglect. Thanks to the Voice of Detroit (VOD), it is now coming to light that the New Oakland Child-Adolescent & Family Center – a private facility which reported Maryanne to CPS for taking her daughter off the drug — has paid connections with Big Pharma since at least 2004.